Loading people...
Abraham Kometz is a Partner on the Medical Technologies team at Deerfield Management, based in New York. Before joining the $10 billion healthcare investment firm in 2014, he worked in the Healthcare Practice at McKinsey & Company, focusing on corporate strategy, valuation, and cost-reduction initiatives. He began his career as a clinical physician after earning his M.D. from the University of the Witwatersrand Medical School in South Africa, where he founded and scaled a regional group of medical clinics. In his current capacity, Kometz leads investment efforts across the medical device sector and serves on the boards of portfolio companies including Endologix and Aviko. His ongoing focus centers on leveraging his clinical and corporate development background to structure venture capital transactions across the biotechnology, pharmaceutical, and healthcare information technology markets.
Abraham Kometz stands as a key Partner at Deerfield Management, a globally recognized investment firm dedicated to advancing healthcare. In his influential role, Mr. Kometz is instrumental in leading and shaping Deerfield's investment strategies, particularly within the dynamic fields of private equity and venture capital. His work focuses on identifying groundbreaking companies and technologies that have the potential to revolutionize patient care and medical science.
Deerfield Management's core mission revolves around investing in companies that are developing solutions to address significant unmet medical needs. Mr. Kometz's investment focus aligns perfectly with this mission, spanning a broad spectrum of the healthcare industry. This includes biotechnology firms pioneering novel therapies, pharmaceutical companies developing life-saving drugs, medical device innovators creating advanced tools, and healthcare service providers enhancing delivery models. He is deeply involved in evaluating potential investments, conducting thorough due diligence, and structuring deals that foster growth and innovation within portfolio companies.
Before his tenure at Deerfield Management, Abraham Kometz built a robust career foundation in finance, equipping him with a comprehensive understanding of market dynamics and investment principles. His background often includes significant experience in investment banking or other financial advisory roles, where he honed his analytical skills and developed a keen eye for value creation. This prior experience provided him with invaluable insights into the complexities of the healthcare sector, preparing him to navigate its unique challenges and opportunities at Deerfield. He is also known for his strong academic background, often holding degrees from prestigious institutions that complement his professional expertise.
While specific individual investments are often proprietary, Mr. Kometz's contributions are integral to Deerfield Management's overall success in backing transformative healthcare ventures. Deerfield has a strong track record of investing in companies that bring innovative drugs to market, develop cutting-edge medical devices, and improve healthcare infrastructure. Abraham Kometz's involvement ensures that Deerfield continues to identify and support enterprises poised for significant impact, driving both financial returns and meaningful advancements in global health. His strategic vision and deep industry knowledge are critical assets in Deerfield's ongoing commitment to fostering innovation across the healthcare ecosystem.
Abraham Kometz is a Partner at Deerfield Management, a leading healthcare-focused investment firm. He specializes in private equity and venture capital investments within the life sciences and healthcare technology sectors.
Abraham Kometz invests in a wide range of healthcare companies through Deerfield Management, including biotechnology, pharmaceuticals, medical devices, and healthcare services. His focus is on innovative solutions addressing unmet medical needs.
Abraham Kometz works as a Partner at Deerfield Management, a prominent investment firm dedicated to advancing healthcare through strategic capital deployment.
